AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Talk-to-Jo" Intelligent Digital Health Companion, Neurocognitive Disorders and Dyads

Recruitingn/aAges 65 Years - anyAllOlivier Beauchet
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

By 2050, one in six people in the world will be over 65, leading to an increase in the number of people with neurocognitive disorders (NCD), such as Alzheimer's disease. The number of cases will rise from 57 million to 153 million by 2050. This presents challenges for healthcare systems, as NCDs affect not only mental health but also the physical health, psychological well-being, and social relationships of patients, as well as their caregivers (PCA). In Quebec, primary care is often inadequate for people living with NCDs due to delays in accessing resources, incomplete coverage of needs, and the COVID-19 pandemic, which has exacerbated these challenges. This situation can lead to a deterioration in patients' health, affecting their quality of life as well as that of their PCAs, while also increasing healthcare costs. Many elderly people wish to age at home, but cognitive and functiona

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
1. Person living with an neurocognitive disorder (NCD): 1. Inclusion criteria: * Be 65 years old or older. * Have an NCD, whether minor or major, in a mild to moderate stage, diagnosed within the past year. * Be receiving care for an NCD at the outpatient clinic of the Montreal Geriatric University Institute. * Have a caregiver. * Live in a personal residence or in a non-medicalized senior residence. * Be able to understand spoken and written French. The "Talk-to-Jo" avatar has only been developed in the French language and can only communicate and understand French. 2. Exclusion criteria: * Inability to provide informed consent for participation in the study. * Participating in a concurrent experimental clinical study, to avoid interference with our study. * Living in a Long-Term Care Facility or in a medicalized section of an non-medicalized senior residence. * Inability to understand spoken and written French. * Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included. 2. Caregiver 1. Inclusion criteria: * Be a caregiver for a person living with an NCD (regardless of the relationship: spouse, child, friend, neighbor, family member). * Be able to understand spoken and written French. 2. Exclusion criteria: * Have an NCD. * Inability to understand spoken and written French. * Participating in a concurrent experimental clinical study, to avoid interference with our study. * Having a moderate to severe visual or auditory impairment. The criterion for assessing hearing impairment will be the person's ability to understand and participate in a phone conversation. Individuals with impairments who use hearing aids or glasses to compensate for the impairments may be included.
๐Ÿ’Š

What it tests

  • Talk-To-Jo
๐Ÿ“

Where

1 site
CRIUGM
Montreal, Canada
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy